Logo image of AGLX.OL

AGILYX ASA (AGLX.OL) Stock Fundamental Analysis

OSL:AGLX - Euronext Oslo - NO0010872468 - Common Stock - Currency: NOK

23.65  -0.2 (-0.84%)

Fundamental Rating

3

Taking everything into account, AGLX scores 3 out of 10 in our fundamental rating. AGLX was compared to 41 industry peers in the Commercial Services & Supplies industry. AGLX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AGLX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

AGLX had negative earnings in the past year.
AGLX had a negative operating cash flow in the past year.
AGLX had negative earnings in 4 of the past 5 years.
In the past 5 years AGLX always reported negative operating cash flow.
AGLX.OL Yearly Net Income VS EBIT VS OCF VS FCFAGLX.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

1.2 Ratios

AGLX's Return On Assets of -11.43% is on the low side compared to the rest of the industry. AGLX is outperformed by 75.61% of its industry peers.
AGLX has a worse Return On Equity (-15.76%) than 68.29% of its industry peers.
Industry RankSector Rank
ROA -11.43%
ROE -15.76%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AGLX.OL Yearly ROA, ROE, ROICAGLX.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

The Gross Margin of AGLX (3.27%) is worse than 80.49% of its industry peers.
AGLX's Gross Margin has improved in the last couple of years.
AGLX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 3.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.08%
GM growth 5YN/A
AGLX.OL Yearly Profit, Operating, Gross MarginsAGLX.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 1K -1K -2K

More info and screens

6

2. Health

2.1 Basic Checks

AGLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
AGLX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AGLX.OL Yearly Shares OutstandingAGLX.OL Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 20M 40M 60M
AGLX.OL Yearly Total Debt VS Total AssetsAGLX.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 10M 20M 30M 40M

2.2 Solvency

An Altman-Z score of 4.05 indicates that AGLX is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.05, AGLX belongs to the top of the industry, outperforming 95.12% of the companies in the same industry.
A Debt/Equity ratio of 0.33 indicates that AGLX is not too dependend on debt financing.
AGLX has a better Debt to Equity ratio (0.33) than 68.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Altman-Z 4.05
ROIC/WACCN/A
WACC8.6%
AGLX.OL Yearly LT Debt VS Equity VS FCFAGLX.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M 30M

2.3 Liquidity

AGLX has a Current Ratio of 27.85. This indicates that AGLX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 27.85, AGLX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
A Quick Ratio of 27.85 indicates that AGLX has no problem at all paying its short term obligations.
AGLX has a Quick ratio of 27.85. This is amongst the best in the industry. AGLX outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 27.85
Quick Ratio 27.85
AGLX.OL Yearly Current Assets VS Current LiabilitesAGLX.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

AGLX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -122.43%.
The Revenue for AGLX has decreased by -92.81% in the past year. This is quite bad
The Revenue for AGLX have been decreasing by -40.89% on average. This is quite bad
EPS 1Y (TTM)-122.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-109%
Revenue 1Y (TTM)-92.81%
Revenue growth 3Y-40.89%
Revenue growth 5YN/A
Sales Q2Q%-90.48%

3.2 Future

Based on estimates for the next years, AGLX will show a very strong growth in Earnings Per Share. The EPS will grow by 26.14% on average per year.
AGLX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.82% yearly.
EPS Next Y23.76%
EPS Next 2Y29.65%
EPS Next 3Y46.9%
EPS Next 5Y26.14%
Revenue Next Year-87.32%
Revenue Next 2Y-16.47%
Revenue Next 3Y1.93%
Revenue Next 5Y20.82%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AGLX.OL Yearly Revenue VS EstimatesAGLX.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10M 20M 30M
AGLX.OL Yearly EPS VS EstimatesAGLX.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.1 -0.1 0.2 -0.2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AGLX. In the last year negative earnings were reported.
Also next year AGLX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AGLX.OL Price Earnings VS Forward Price EarningsAGLX.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AGLX.OL Per share dataAGLX.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

A more expensive valuation may be justified as AGLX's earnings are expected to grow with 46.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.65%
EPS Next 3Y46.9%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AGLX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AGILYX ASA

OSL:AGLX (8/6/2025, 10:20:06 AM)

23.65

-0.2 (-0.84%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)04-24 2025-04-24/amc
Earnings (Next)08-21 2025-08-21
Inst Owners23.87%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap2.61B
Analysts84.44
Price Target37.74 (59.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.33%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-96.03%
Revenue NY rev (3m)-96.03%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 251.99
P/FCF N/A
P/OCF N/A
P/B 1.82
P/tB 1.86
EV/EBITDA N/A
EPS(TTM)-2.26
EYN/A
EPS(NY)-1.5
Fwd EYN/A
FCF(TTM)-0.93
FCFYN/A
OCF(TTM)-0.93
OCFYN/A
SpS0.09
BVpS12.99
TBVpS12.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.43%
ROE -15.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 3.27%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.08%
GM growth 5YN/A
F-Score2
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.91%
Cap/Sales 4.55%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 27.85
Quick Ratio 27.85
Altman-Z 4.05
F-Score2
WACC8.6%
ROIC/WACCN/A
Cap/Depr(3y)323.04%
Cap/Depr(5y)265.24%
Cap/Sales(3y)48.68%
Cap/Sales(5y)33.04%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-122.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-109%
EPS Next Y23.76%
EPS Next 2Y29.65%
EPS Next 3Y46.9%
EPS Next 5Y26.14%
Revenue 1Y (TTM)-92.81%
Revenue growth 3Y-40.89%
Revenue growth 5YN/A
Sales Q2Q%-90.48%
Revenue Next Year-87.32%
Revenue Next 2Y-16.47%
Revenue Next 3Y1.93%
Revenue Next 5Y20.82%
EBIT growth 1Y60.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year39.98%
EBIT Next 3Y34.94%
EBIT Next 5Y51.38%
FCF growth 1Y53.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.93%
OCF growth 3YN/A
OCF growth 5YN/A